Author:
DOĞAN ULUTAŞ Perihan Özlem,BAKARIŞ Sevgi,GÜLER ŞİMŞEK Gülçin
Reference24 articles.
1. Referans1. Global Cancer Observatory, France: International Agency for Research on Cancer, World Health Organization. Breast Cancer Incidence, Mortality and Prevalence Worldwide in 2020; [accessed February 26, 2022]. Available from https://gco.iarc.fr/today/home
2. Referans2. Norberg T, Jansson T, Sjoügren S, et al. Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53. Acta Oncologica 1996;35:96-102.
3. Referans3. Korkolis DP, Tsoli E, Fouskakis D, et al. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients. Anticancer Res. 2004;24:2061-2068.
4. Referans4. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86(3):353–364.
5. Referans5. Maschio LB, Madallozo BB, Capellasso BA, et al. Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1α and CD34 in invasive ductal carcinoma of the breast. Acta Histochem. 2014;116(1):148-157.